ziru DAI

Prof. ziru DAI

Beibu Gulf university
orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 July 2021 in Food Science & Nutrition
Verified
Journal Article
Open access
PDF file
YKYan Kong
Yan Kong
YLYing Li
Ying Li
ZDziru DAI
ziru DAI
MQMei Qin
Mei Qin
HFHe‐Liang Fan
He‐Liang Fan
PWPei Wang
Pei Wang
Hyperlipidemia an immense group of acquired or genetic metabolic disorders that is characterized by an excess of lipids in the bloodstream. Altogether, they have a high prevalence worldwide and constitute a major threat to human health. Glycosaminoglycans (GAG) are natural biomolecules that have hypolipidemic activity. The purpose of this study was to investigate the potential hypolipidemic effect of glycosaminoglycans extracted from Ostrea rivularis (OGAG) on hyperlipidemic zebrafish, as well as the possible underlying mechanism of such effect. Dietary supplementation with OGAG during 4 weeks significantly reduced the serum and hepatic lipid levels and the hepatosomatic index in hyperlipidemic zebrafish. In addition, histopathological showed that OGAG supplementation decreases the volume and number of lipid droplets in hepatocytes. Transcriptome and real‐time quantitative polymerase chain reaction analysis revealed that the gene expression levels of PPARγ, SCD, HMGRA, ACAT2, HMGCS, and HMGCR were significantly downregulated by OGAG treatment in hepatocytes, whereas those of CD36, FABP2, FABP6, ABCG5, and CYP7A1 were significantly upregulated. This suggests that the hypolipidemic effect of OGAG relies on increasing the ketogenic metabolism of fatty acids, inhibiting cholesterol synthesis, and enhancing the transformation of cholesterol to bile acid. Furthermore, OGAG treatment improved gut microbiota imbalance by reducing the Firmicutes‐to‐Bacteroidetes ratio, increasing the relative abundance of beneficial bacteria (Bacteroidetes, Verrucomicrobia, Acidobacteria, and Sphingomonas), and reducing the relative abundance of harmful bacteria (Proteobacteria, Cohaesibacter, Vibrio, and Terrisporobacter). These findings highlight the potential benefit of implementing OGAG as a dietary supplement to prevent and treat hyperlipidemia.

30 October 2024 in Food Research International
Verified
Journal Article
Closed access
FTFuyao Tan
Fuyao Tan
MLMingzhu Liu
Mingzhu Liu
HTHuaimao Tie
Huaimao Tie
BLBingji Liu
Bingji Liu
XZXuefeng Zeng
Xuefeng Zeng
ZDziru DAI
ziru DAI

15 August 2023 in ACS Food Science & Technology
Verified
Journal Article
Open access
FTFuying Tao
Fuying Tao
PWPei Wang
Pei Wang
ZDziru DAI
ziru DAI
CZChenxiao Zhang
Chenxiao Zhang
DLDongliang Li
Dongliang Li
JHJunguang Hao
Junguang Hao

8 September 2024 in Biomedicine & Pharmacotherapy
Verified
Journal Article
Open access
FQFengqing Qin
Fengqing Qin
MZMing Zhang
Ming Zhang
PWPei Wang
Pei Wang
ZDziru DAI
ziru DAI
XLXi Li
Xi Li
TWTianci Wang
Tianci Wang
As the global population ages, the incidence of Parkinson's Disease (PD) continues to rise, imposing significant social and economic burdens. Mangiferin (MGF), a polyphenolic, bioactive compound has been shown to play a role in the prevention and treatment of PD. This study investigates the neuroprotective effects of MGF in an MPTP-induced zebrafish model of PD through transcriptome analysis. Initially, optimal concentrations for modeling were determined using various MPTP and MGF combinations. The zebrafish were then divided into control, MPTP-treated, and MGF co-treated groups. Subsequent evaluations included hatching rates, mortality rates, growth and development conditions, spontaneous motor abilities, as well as measurements of enzymatic activities of SOD, CAT, and levels of GSH. Ultimately, the therapeutic efficacy of MGF on the PD model in zebrafish was assessed through transcriptome sequencing. The results demonstrated that MPTP treatment induced PD-associated symptoms in zebrafish, while MGF treatment significantly improved the motor abilities and survival rates of the PD model zebrafish, effectively reducing oxidative stress and ameliorating PD symptoms. Transcriptome sequencing further revealed that MGF may mitigate mitochondrial-related oxidative stress in PD zebrafish by modulating the expression of critical genes including lrrk2, vps35, atp13a, dnajc6, and uchl1. Differential gene expression analysis indicated that these genes are primarily involved in vital signaling pathways, such as neuroactive ligand-receptor interaction, and the calcium signaling pathway. In summary, our study provides robust scientific evidence supporting MGF as a potential therapeutic candidate for PD by preserving mitochondrial homeostasis and elucidating its mechanisms of action.

14 September 2020 in Current Microbiology
Verified
Journal Article
Closed access
PDF file
PWPei Wang
Pei Wang
YNYi Ning
Yi Ning
JHJingcai Huang
Jingcai Huang
ZDziru DAI
ziru DAI
HWHong Wang
Hong Wang
YLYongyan Liao
Yongyan Liao

31 January 2026 in Carbohydrate Polymers
Verified
Journal Article
Closed access
DLDehong Lu
Dehong Lu
HYHuimin Yao
Huimin Yao
NSNouman Ali Shah
Nouman Ali Shah
SASajid Ali
Sajid Ali
LZLi-Yan Zeng
Li-Yan Zeng
HJHafiz Umer Javed
Hafiz Umer Javed